Shrestha N - Search Results

1

Short-Term Intravenous Administration of Carbon Nano-Onions is Non-Toxic in Female Mice.

Tan YZ, Thomsen LR, Shrestha N, Camisasca A, Giordani S, Rosengren R. Tan YZ, et al. Among authors: shrestha n. Int J Nanomedicine. 2023 Jul 17;18:3897-3912. doi: 10.2147/IJN.S414438. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37483316 Free PMC article.

2

Does Crizotinib Auto-Inhibit CYP3A in vivo?

Bland AR, Shrestha N, Rosengren RJ, Ashton JC. Bland AR, et al. Among authors: shrestha n. Pharmacology. 2020;105(11-12):715-718. doi: 10.1159/000506996. Epub 2020 May 27. Pharmacology. 2020. PMID: 32460299

3

The effect of metformin in EML₄-ALK+ lung cancer alone and in combination with crizotinib in cell and rodent models.

Bland AR, Shrestha N, Bower RL, Rosengren RJ, Ashton JC. Bland AR, et al. Among authors: shrestha n. Biochem Pharmacol. 2021 Jan;183:114345. doi: 10.1016/j.bcp.2020.114345. Epub 2020 Nov 21. Biochem Pharmacol. 2021. PMID: 33227290

4

Does the mouse tail vein injection method provide a good model of lung cancer?

Shrestha N, Lateef Z, Martey O, Bland AR, Nimick M, Rosengren R, Ashton JC. Shrestha N, et al. F1000Res. 2019 Feb 15;8:190. doi: 10.12688/f1000research.17964.1. eCollection 2019. F1000Res. 2019. PMID: 31448098 Free PMC article.

5

Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer.

Shrestha N, Nimick M, Dass P, Rosengren RJ, Ashton JC. Shrestha N, et al. Sci Rep. 2019 Dec 11;9(1):18842. doi: 10.1038/s41598-019-55376-4. Sci Rep. 2019. PMID: 31827192 Free PMC article.

6

Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer.

Shrestha N, Bland AR, Bower RL, Rosengren RJ, Ashton JC. Shrestha N, et al. J Pharmacol Exp Ther. 2020 Jul;374(1):134-140. doi: 10.1124/jpet.120.266049. Epub 2020 Apr 13. J Pharmacol Exp Ther. 2020. PMID: 32284325

7

Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance.

Bland AR, Shrestha N, Berry M, Wilson C, Ashton JC. Bland AR, et al. Among authors: shrestha n. Curr Cancer Drug Targets. 2022;22(2):97-107. doi: 10.2174/1568009622666220107152014. Curr Cancer Drug Targets. 2022. PMID: 34994310

8

A real-world study of the quality of Outpatient Pain Management in patients with Cancer.

Adhikari B, Shrestha N, Bhatt VR. Adhikari B, et al. Among authors: shrestha n. J Cancer Surviv. 2024 May 25. doi: 10.1007/s11764-024-01621-3. Online ahead of print. J Cancer Surviv. 2024. PMID: 38795285

9

The bioelectric mechanisms of local calcium dynamics in cancer cell proliferation: an extension of the A549 in silico cell model.

Langthaler S, Zumpf C, Rienmüller T, Shrestha N, Fuchs J, Zhou R, Pelzmann B, Zorn-Pauly K, Fröhlich E, Weinberg SH, Baumgartner C. Langthaler S, et al. Among authors: shrestha n. Front Mol Biosci. 2024 May 6;11:1394398. doi: 10.3389/fmolb.2024.1394398. eCollection 2024. Front Mol Biosci. 2024. PMID: 38770217 Free PMC article.

10

[¹⁸F]FDG PET/CT for identifying the causes of fever of unknown origin (FUO).

Singh SB, Shrestha N, Bhandari S, Shrestha S, Shrestha B, Shrestha N, Rijal S, Singh R, Hess S, Werner TJ, Alavi A, Revheim ME. Singh SB, et al. Among authors: shrestha n. Am J Nucl Med Mol Imaging. 2024 Apr 25;14(2):87-96. doi: 10.62347/OQQC6007. eCollection 2024. Am J Nucl Med Mol Imaging. 2024. PMID: 38737639 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

785 results

Search Page